Travere Therapeutics reported an earnings shortfall of $0.57 compared with expectations, according to the available earnings update. Despite the miss on earnings, the company’s revenue surpassed estimates.
The information provided does not include the company’s reported earnings figure, revenue amount, analyst consensus, or management commentary. Investors should also consider that financial-market data may be delayed or indicative rather than real-time, and that trading involves the risk of losing part or all of the invested capital.
Sources: Investing.com News.